We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Barco Awarded for Leadership in European Medical Display Market

By MedImaging staff writers
Posted on 06 Mar 2007
Visualization specialist Barco (Kortrijk, Belgium) has been granted the 2006 Award for Market Leadership in the European medical display market by global growth consulting company Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company.

The award is presented each year to the company that has established itself as the market leader in its respective industry, based on criteria such as market share, revenue growth rates, profitability, market strategy, and technology innovation. More...


"The key to long-term market leadership lies in responding to the demands of a modern hospital environment whilst while simultaneously maintaining and nurturing traditional relationships with both hospitals and medical imaging partners. Barco has demonstrated great focus in adapting to a changing hospital environment, ensuring that it remains the first choice for medical displays in the future,” explained Martin Bryant, medical imaging program leader Frost & Sullivan. "An inventive marketing strategy has been successfully supported by innovative R&D to ensure that Barco remains at the forefront of developing market trends. These efforts have consolidated Barco's number one position in the market for medical displays in Europe.”

Luc Colle, regional director of Barco's Medical Imaging Division, stated, "We are proud to see our vision and market approach endorsed by this prestigious award. It recognizes our profound commitment to deliver innovative imaging solutions that enable our customers all over the globe to enhance the performance of their digital imaging equipment, be it for diagnosis, viewing, referral, or surgical planning.”

Barco's dedication and market leadership is demonstrated in the breadth and diversity of its recent product innovations, according to Frost & Sullivan. In addition to new generations of its successful Nio and Coronis diagnostic display systems, Barco introduced a new range of advanced display systems for the integrated operating room (OR) and a new generation of its powerful Voxar three-dimensional (3D) sophisticated visualization tools. Furthermore, Barco recently launched of Medical QAWEB, the industry's first online service for high-grade quality assurance of picture archiving communication system (PACS) display systems.

Barco, a global technology company, designs, and develops visualization products for a variety of professional markets.


Related Links:
Barco
Frost & Sullivan

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.